뉴스/Reuters/UCB Announces Positive Phase 3 Studies For Bimekizumab In Hidrade…UCB Announces Positive Phase 3 Studies For Bimekizumab In Hidradenitis Suppurativa2022년 12월 9일13:54 UTCUCBUCB SA UCB:UCB ANNOUNCES POSITIVE PHASE 3 STUDIES FOR BIMEKIZUMAB IN HIDRADENITIS SUPPURATIVA